Last updated: 2026-10-13 09:17:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Mannatech Inc. (MTEX) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $7.73, with a market capitalisation of $15.17M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.80 to $12.45. This page covers its latest market performance, valuation, price trends and company information.
$15.17M | |
$7.35 | |
$261.00 | |
$3.14 | |
$7.86 | |
32.74K | |
27.61K | |
-- | |
$12.45 | |
$3.80 | |
-- | |
-- |
Mannatech Inc. (MTEX) is trading at $7.78 in pre-market trading as of 2026-10-12 23:31:00, down 0.98% ($0.08) from the previous close of $7.86
Pre-market trading shows how investors are pricing MTEX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Mannatech Inc. (MTEX) moved from $6.64 to $7.73, representing a gain of 16.37% ($1.09).
The stock traded between $6.29 and $8.13 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 29.00 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 45.4%
MTEX is currently trading at $7.73, placing it 45.4% of the way from its 52-week low of $3.80 to its 52-week high of $12.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 170 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mannatech Inc. (MTEX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.